- Report
- January 2022
- 200 Pages
Global
From €5187EUR$5,250USD£4,318GBP
€7411EUR$7,500USD£6,168GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- November 2023
- 81 Pages
India
From €3458EUR$3,500USD£2,878GBP
- Report
- November 2023
- 181 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- November 2023
- 188 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- October 2023
- 172 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- June 2022
- 120 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- November 2021
- 120 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- April 2023
- 147 Pages
Global
From €5927EUR$5,999USD£4,934GBP
The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more